Should public reporting be made for performance indicators on healthcare-associated infections?

被引：5

作者：

Lucet, J. -C. ^{[1
,2
]}

Parneix, P. ^{[3
]}

Grandbastien, B. ^{[4
]}

Berthelot, P. ^{[5
,6
]}

机构：

[1] Hop Bichat Claude Bernard, AP HP, Unite Hyg & Lutte Infect Nosocomiale, F-75018 Paris, France

[2] Univ Paris Diderot, Sorbonne Paris Cite, F-75205 Paris 13, France

[3] CHU Bordeaux, Hop Pellegrin, CClin Sud Ouest, F-33076 Bordeaux, France

[4] CHRU Lille, Hop Calmette, SGRIVi, F-59037 Lille, France

[5] CHU St Etienne, Serv Malad Infect, Unite Hyg Interhosp, F-42055 St Etienne 2, France

[6] CHU St Etienne, Lab Microbiol, F-42055 St Etienne 2, France

来源：

MEDECINE ET MALADIES INFECTIEUSES | 2013年 / 43卷 / 03期

关键词：

Healthcare-associated infection; Nosocomial infection; Indicator; Quality improvement; Public reporting; NOSOCOMIAL INFECTIONS; SURVEILLANCE; QUALITY; NONPAYMENT; IMPACT; ZERO;

D O I：

10.1016/j.medmal.2013.03.002

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

There are still many uncertainties regarding the benefit of public reporting on indicators of healthcare-associated infections. Publishing the results of performance indicators in healthcare facilities seems to stimulate quality insurance activity, but for the moment, without any demonstrated impact on the rates of healthcare-associated infections. Furthermore, it is not proved that public reporting of these results is beneficial. The French Society for Hospital Hygiene, in this synthesis, considered the advantages and drawbacks of public reporting of healthcare-associated infections. Beyond the difficult choice of indicators, public reporting of such indicators requires taking many precautions listed in this article, including a broad dialogue between the various stakeholders involved, a test period, and mandatory control of the produced indicator validity by health authorities. (c) 2013 Elsevier Masson SAS. All rights reserved.

引用

页码：108 / 113

页数：6

共 50 条

[31] Healthcare-associated infections in rheumatology in Japan
Masahiro Iwamoto
Takeshi Kamimura
Takao Nagashima
Yasuyuki Kamata
Yoko Aoki
Sachiko Onishi
Seiji Minota
Rheumatology International, 2012, 32 : 801 - 804
[32] Prevention and treatment of healthcare-associated infections
Chang, Mee Soo
Woo, Jun Hee
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2016, 59 (08): : 622 - 628
[33] Impact of organizations on healthcare-associated infections
Castro-Sanchez, E.
Holmes, A. H.
JOURNAL OF HOSPITAL INFECTION, 2015, 89 (04) : 346 - 350
[34] Legal liability for healthcare-associated infections
Zielinski, Grzegorz
Kanecki, Krzysztof
Lewtak, Katarzyna
FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2022, 24 (02): : 172 - 176
[35] Healthcare-associated infections in rheumatology in Japan
Iwamoto, Masahiro
Kamimura, Takeshi
Nagashima, Takao
Kamata, Yasuyuki
Aoki, Yoko
Onishi, Sachiko
Minota, Seiji
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (03) : 801 - 804
[36] PATIENT SAFETY AND HEALTHCARE-ASSOCIATED INFECTIONS
Yaneva-Deliverska, M.
JOURNAL OF IMAB, 2011, 17 (01): : 120 - 122
[37] Controlling healthcare-associated infections in the NHS
Duerden, Brian
CLINICAL MEDICINE, 2008, 8 (02) : 140 - 143
[38] Influence of State Laws Mandating Reporting of Healthcare-Associated Infections: The Case of Central Line-Associated Bloodstream Infections
Pakyz, Amy L.
Edmond, Michael B.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (08): : 780 - 784
[39] Bloodstream infections in adults:: Importance of healthcare-associated infections
Valles, J.
Calbo, E.
Anoro, E.
Fontanals, D.
Xercavins, M.
Espejo, E.
Serrate, G.
Freixas, N.
Morera, M. A.
Font, B.
Bella, F.
Segura, F.
Garau, J.
JOURNAL OF INFECTION, 2008, 56 (01) : 27 - 34
[40] Qualitative study of views and experiences of performance management for healthcare-associated infections
Brewster, L.
Tarrant, C.
Dixon-Woods, M.
JOURNAL OF HOSPITAL INFECTION, 2016, 94 (01) : 41 - 47

← 1 2 3 4 5 →